Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Keywords
- RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Fingerprint
Dive into the research topics where Rebecca Marlow is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 19 Article
-
CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models
Cheung, A., Chenoweth, A. M., Quist, J., Sow, H. S., Malaktou, C., Ferro, R., Hoffmann, R. M., Osborn, G., Sachouli, E., French, E., Marlow, R., Lacy, K. E., Papa, S., Grigoriadis, A. & Karagiannis, S. N., 11 Jul 2022, In: Cancers. 14, 14, 21 p., 3361.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Citations (Scopus)57 Downloads (Pure) -
3D functional genomics screens identify CREBBP as a targetable driver in aggressive triple-negative breast cancer
Peck, B., Bland, P., Mavrommati, I., Muirhead, G., Cottom, H., Wai, P. T., Maguire, S. L., Barker, H. E., Morrison, E., Kriplani, D., Yu, L., Gibson, A., Falgari, G., Brennan, K., Farnie, G., Buus, R., Marlow, R., Novo, D., Knight, E., Guppy, N., & 22 others, 15 Feb 2021, In: Cancer Research. 81, 4, p. 847-859 13 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
Zatreanu, D., Robinson, H. M. R., Alkhatib, O., Boursier, M., Finch, H., Geo, L., Grande, D., Grinkevich, V., Heald, R. A., Langdon, S., Majithiya, J., McWhirter, C., Martin, N. M. B., Moore, S., Neves, J., Rajendra, E., Ranzani, M., Schaedler, T., Stockley, M., Wiggins, K., & 41 others, Dec 2021, In: Nature Communications. 12, 1, 3636.Research output: Contribution to journal › Article › peer-review
Open Access131 Citations (Scopus) -
Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)
Hoffmann, R. M., Mele, S., Cheung, A., Larcombe-Young, D., Bucaite, G., Sachouli, E., Zlatareva, I., Morad, H. O. J., Marlow, R., McDonnell, J. M., Figini, M., Lacy, K. E., Tutt, A. J. N., Spicer, J. F., Thurston, D. E., Karagiannis, S. N. & Crescioli, S., 1 Jun 2020, In: Scientific Reports. 10, 1, p. 8869 8869.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Citations (Scopus)42 Downloads (Pure) -
Rapid conjugation of antibodies to toxins to select candidates for the development of anti-cancer Antibody-Drug Conjugates (ADCs)
Hoffmann, M., Mele, S., Cheung, A., Larcombe-Young, D., Bucaite, G., Sachouli, E., Zlatareva, I., Morad, H., Marlow, R., McDonnell, J., Figini, M., Lacy, K. E., Tutt, A., Spicer, J., Thurston, D., Karagiannis, S. N. & Crescioli, S., 1 Jun 2020, In: Scientific Reports. 10, 1, 22 p., 8869.Research output: Contribution to journal › Article › peer-review
Open AccessFile109 Downloads (Pure)
Projects
- 4 Finished
-
Towards in vitro oncology trials: drug testing in cultured patient derived tumour organoid cultures.
1/09/2016 → 31/08/2019
Project: Research
-
Characterization of the immune microenvironment present in murine models of triple-negative breast cancer
Tutt, A., Hayday, A., Kyle Cezar, F. & Marlow, R.
1/01/2015 → 1/01/2016
Project: Research
-
Validation of GPR89 as a drug discovery target for triple-negative breast cancer
Tutt, A., Marlow, R. & academic, A.
1/06/2014 → 31/05/2015
Project: Research